2020
DOI: 10.1001/jama.2020.7058
|View full text |Cite
|
Sign up to set email alerts
|

Continuous Glucose Monitoring in Adolescent, Young Adult, and Older Patients With Type 1 Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 16 publications
1
7
0
Order By: Relevance
“…The only caveat mentioned by some parents was insurance coverage determining their ability to continue using CGM. This finding is consistent with prior research demonstrating that insurance coverage, or lack thereof, determines whether individuals and families are able to sustain CGM use 4,25‐27 . In the United States, individuals from lower socio‐economic groups use CGM at significantly lower rates than those from higher socio‐economic groups; this relationship between socio‐economic status and CGM use is not seen in Germany where insurance and health care delivery differ from the United States 28 .…”
Section: Discussionsupporting
confidence: 89%
See 1 more Smart Citation
“…The only caveat mentioned by some parents was insurance coverage determining their ability to continue using CGM. This finding is consistent with prior research demonstrating that insurance coverage, or lack thereof, determines whether individuals and families are able to sustain CGM use 4,25‐27 . In the United States, individuals from lower socio‐economic groups use CGM at significantly lower rates than those from higher socio‐economic groups; this relationship between socio‐economic status and CGM use is not seen in Germany where insurance and health care delivery differ from the United States 28 .…”
Section: Discussionsupporting
confidence: 89%
“…This finding is consistent with prior research demonstrating that insurance coverage, or lack thereof, determines whether individuals and families are able to sustain CGM use. 4,[25][26][27] In the United States, individuals from lower socio-economic groups use CGM at significantly lower rates than those from higher socio-economic groups; this relationship between socio-economic status and CGM use is not seen in Germany where insurance and health care delivery differ from the United States. 28 Many in the current study described the technology as a 'necessity' for their child's diabetes care that they would not want to give up.…”
Section: Subtheme Example Quotementioning
confidence: 99%
“…According to recent T1D Exchange data, only 10.5% of YAs with type 1 diabetes in the United States are meeting glycemic targets (50); many also experience greater frequency of acute complications (51) and substantially lower rates of diabetes device use compared with older adults (52)(53)(54). YAs endorse barriers to using diabetes devices, including physical hassles with wearing devices and not wanting devices to draw attention from others (52,55).…”
Section: Physical and Psychosocial Tollsmentioning
confidence: 99%
“…Additionally, there is evidence that insufficient insurance coverage contributes to lower diabetes technology adoption among YAs (56). Finally, the experience of life with diabetes is not equal across all YAs, as research documents racial and ethnic disparities in glycemic levels, diabetes device use, and emotional distress among YAs (53,57,58).…”
Section: Physical and Psychosocial Tollsmentioning
confidence: 99%
“…10,11 Technological advancements in blood glucose monitoring have led to the development of continuous glucose monitoring (CGM), which provides a sustained, visible measure of variations of the individual's glucose levels in real time. 12,13 Research has shown possible treatment outcomes improvement when using CGM, 14,15 while the psychological barriers and benefits that accompany the use of CGM systems have indicated that employing this facility to form part of the diabetes care plan holds multiple benefits for the users. 16 For example, patients using CGM have an increased chance of achieving greater control over managing their blood glucose levels, which, in turn, offers the possibility of decreased levels of fear, improved quality of life and a sense of empowerment.…”
Section: Introductionmentioning
confidence: 99%